Cavan Redmond named president of Wyeth Consumer Healthcare

MADISON, N.J. As part of a series of executive promotions announced Friday morning, Wyeth named Cavan Redmond president of its Wyeth Consumer Healthcare effective Dec. 1.

Redmond, 46, will be responsible for the division’s global operations. The company also announced that Douglas Rogers, 47, has been named to the position of president, U.S. and global new business, Wyeth Consumer Healthcare.

“Under Cavan’s leadership, Wyeth has become the third largest biotech company in the world. We know he’ll bring the same formula for success to our consumer brands,” stated Bernard Poussot, Wyeth president and chief operating officer. “In addition, Doug’s marketing and commercial skills, coupled with his in-depth knowledge, energy and experience, will serve as a tremendous advantage for the division.”

Redmond has been serving as executive vice president and general manager of the BioPharma business unit of Wyeth Pharmaceuticals. He also has held positions of increasing responsibility in the commercial and R&D organizations. Prior to joining Wyeth Pharmaceuticals, Redmond worked at Sandoz both in the United States and in Switzerland. He earned a bachelor’s degree in political science from the University of Maryland and a master’s degree in administration from The Johns Hopkins University. He also completed a post-graduate fellowship in organizational change management.

Most recently, Rogers served as president, Wyeth Consumer Healthcare, and prior to that, he served as president, Wyeth Consumer Healthcare, U.S. He joined Wyeth in November 1994 with the acquisition of American Cyanamid, where he was vice president of marketing for Lederle Consumer Health. Before that, he held various sales and marketing positions for Lederle Pharmaceuticals, Lederle Consumer Health, American Home Foods and Wyeth Consumer Healthcare. He holds a Bachelor’s degree in journalism and an M.B.A., both from Lehigh University.